University of Vermont is a clinical research site located in Burlington, Vermont, United States 05401.
Crixeo Clinical Trials Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Vermont has participated in 209 clinical trials with 39 currently active.
Therapeutic areas: Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.
Sponsors: ECOG-ACRIN Cancer Research Group, National Center for Research Resources (NCRR), California Pacific Medical Center Research Institute.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Vermont · View every site in Burlington
Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Vermont has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Vermont has 209 clinical trials on record, with 39 currently active. Their work covers Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.
University of Vermont has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.